- Home
- SVRA vs CTO Comparison
SVRA vs CTO Comparison
Compare SVRA & CTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRA
- CTO
- Stock Information
- Founded
- SVRA N/A
- CTO 1902
- Country
- SVRA United States
- CTO United States
- Employees
- SVRA N/A
- CTO N/A
- Industry
- SVRA Biotechnology: Pharmaceutical Preparations
- CTO Real Estate Investment Trusts
- Sector
- SVRA Health Care
- CTO Real Estate
- Exchange
- SVRA Nasdaq
- CTO Nasdaq
- Market Cap
- SVRA 458.2M
- CTO 580.9M
- IPO Year
- SVRA N/A
- CTO N/A
- Fundamental
- Price
- SVRA $2.85
- CTO $19.78
- Analyst Decision
- SVRA Buy
- CTO Strong Buy
- Analyst Count
- SVRA 7
- CTO 4
- Target Price
- SVRA $9.86
- CTO $21.50
- AVG Volume (30 Days)
- SVRA 1.0M
- CTO 220.6K
- Earning Date
- SVRA 03-06-2025
- CTO 02-20-2025
- Dividend Yield
- SVRA N/A
- CTO 7.68%
- EPS Growth
- SVRA N/A
- CTO N/A
- EPS
- SVRA N/A
- CTO 0.61
- Revenue
- SVRA N/A
- CTO $118,662,000.00
- Revenue This Year
- SVRA N/A
- CTO N/A
- Revenue Next Year
- SVRA N/A
- CTO $13.12
- P/E Ratio
- SVRA N/A
- CTO $32.77
- Revenue Growth
- SVRA N/A
- CTO 16.61
- 52 Week Low
- SVRA $2.59
- CTO $16.16
- 52 Week High
- SVRA $5.70
- CTO $21.15
- Technical
- Relative Strength Index (RSI)
- SVRA 45.63
- CTO 53.69
- Support Level
- SVRA $2.62
- CTO $19.26
- Resistance Level
- SVRA $2.88
- CTO $19.77
- Average True Range (ATR)
- SVRA 0.19
- CTO 0.35
- MACD
- SVRA 0.02
- CTO 0.04
- Stochastic Oscillator
- SVRA 40.37
- CTO 73.26
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About CTO CTO Realty Growth Inc.
CTO Realty Growth Inc is a Florida-based real estate investment trust company, that owns income properties comprised of approximately 2.7 million square feet in diversified markets in the United States. Its portfolio of assets consists of Income Properties Portfolio, management services, Commercial Loan and Investments.